Stature as a prognostic factor in cystic fibrosis survival

Journal of the American Dietetic Association

Volumn 101, Issue 4, 2001, Pages 438-442

  Beker, Leila T ^a   Russek Cohen, Estelle ^b   Fink, Robert J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ARTICLE; BODY HEIGHT; CHILD; CYSTIC FIBROSIS; EPIDEMIOLOGY; FEMALE; GROWTH DISORDER; HUMAN; LONGITUDINAL STUDY; MALE; MORTALITY; NUTRITIONAL DISORDER; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; SURVIVAL; TIME; UNITED STATES;

AGE FACTORS; BODY HEIGHT; CHILD; CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; COHORT EFFECT; CYSTIC FIBROSIS; FEMALE; GROWTH DISORDERS; HUMANS; LONGITUDINAL STUDIES; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SURVIVAL ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 0035321043     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(01)00113-4     Document Type: Article

References (46)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993; 122:1-9.
2. Cystic Fibrosis Foundation Patient Registry Annual Data Report, 1994. Bethesda, Md, 1995.
3. Fiel S, FitzSimmons S, Schidlow D. Evolving demographics of cystic fibrosis. Semin Res Crit Care Med. 1994; 15:157-196.
4. Shalon LB, Adelson JW. Cystic fibrosis: Gastrointestinal complications and gene therapy. Pediatr Gastroenterol I. 1996; 43:157-196.
5. Colin AA. Cystic Fibrosis. Pediatr Rev. 1994; 15:192-200.
6. Davis PB. Cystic fibrosis: New perceptions, new strategies. Hosp Pract 1992; :79-118.
7. Collins F. Cystic fibrosis: Molecular biology and therapeutic implications. Science 1992; 256:774-779.
8. Cystic Fibrosis Patient Registry Annual Data Report, 1998. Bethesda, Md: Cystic Fibrosis Foundation: 1999.
9. Ramsey BW, Farrel PM, Pencharz P. Nutritional assessment and management in cystic fibrosis: A consensus report. Am J Clin Nutr. 1992;55:108-116.
10. McNaughton SA, Sheperd RW, Greer RG, Clegborn GJ, Thomas BJ. Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: Lack of sensitivity of anthropometric measures. J Pediatr. 2000;136:188-194.
11. Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41:583-591.
12. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol. 1996;143:1007-1017.
13. Lai HC, Kosorok M, Sondel S, Chen S, FitzSimmons S, Green C, Shen G, Walker S, Farrell P. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry Data: Evaluation of various criteria used to identify malnutrition. J Pediatr. 1998; 132:478-485.
14. Lai H-C, Corey M, FitzSimmons S, Kosorok MR, Farrell PM. Comparison of growth status of patients with cystic fibrosis between the United States and Canada. Am J Clin Nutr. 1999;69:531-538.
15. Waterlow J. Classification and definition of protein calorie malnutrition. BMJ. 1972;3:566-569.
16. Luder E, Kattan M, Thornton JC, Koehler KM, Bonforte RJ. Efficacy of non-restricted fat diet in patients with cystic fibrosis. Am J Dis Child. 1989;143:458-464.
17. Davis PB, Kercsmar CM. Growth in children with chronic lung disease. N Engl J Med. 2000;342:887-888.
18. George D, Mangos J. Nutritional management and pancreatic enzyme therapy in cystic fibrosis: State of the art in 1987 and projections into the future. J Pediatr Gastroenterol Nutr. 1988;13:111-136.
19. Pencharz PB, Durie PR. Nutritional managment of cystic fibrosis. Ann Rev Nutr. 1993;13:111-136.
20. Erdman SH. Nutritional imperatives in cystic fibrosis therapy. Pediatr Ann. 1999;28:129-135.
21. Hamill P, Drizd T, Johnson C, Reed R, Roche A, Moore W. Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr. 1979;32:602-629.
22. Rosenfeld M, Davis R, FitsSimmons S, M P, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145:794-803.
23. Bell S, Bowerman A, Davies C, Campbell I, Shale D, Elborn J. Nutrition in adults with cystic fibrosis. Clin Nutr. 1998; 17:211-215.
24. Kalbfleisch J, Prentice R. Statistical analysis of failure time data. New York: John Wiley and Sons, 1980.
25. Selvin S. Practical Biostatistical Methods. An International Thompson Publishing Co (ITP) Belmont, CA: Duxbury Press, 1995.
26. Reilly JJ, Edwards CA, Weaver LT. Malnutrition in children with cystic fibrosis: The energy-balance equation. J Pediatr Gastroenterol Nutr. 1997;25:127-136.
27. Zemel B, Kawchak D, Cnaan A, Zhao H, Scanlin T, Stallings V. Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function and genotype in children with cystic fibrosis. Pediatr Res. 1996;40:578-586.
28. Frongillo E. Symposium: Causes and etiology of stunting. J Nutr. 1999;129:529S-530S.
29. Stephensen CB. Burden of infection on growth failure. J Nutr. 1999;129:534S-538S.
30. Jelalian E, Stark L, Reynolds L, Seifer R. Nutrition intervention for weight gain in cystic fibrosis: A meta analysis. J Pediatr. 1998;132(3 Pt 1):486-492.
31. Brady MS, Ricard K, Yu P-L, Eigen H. Effectiveness and safety of small vs large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: A prospective randomized study. Pediatr Pulm. 1991;10:79-85.
32. Brady MS, Rickard K, Yu P-L, Eigen H. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. J Am Diet Assoc. 1992;92:813-817.
33. Beker LT, Fink RJ, Shams FH, Chaney HR, Kluft J, Evans E, Schidlow DV. Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1994;19:191-197.
34. Mischler EH, Parrel S, Farrell P, Odell GB. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis. Am J Dis Child 1982;132:1060-1063.
35. Ansaldi-Balocco N, Santini B, Sarchi C. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: Comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. J Pediatr Gastroenterol Nutr. 1988;7(Suppl 1):S40-S45.
36. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996;335:179-188.
37. Kawchak D, Zhao H, Scanlin T, Tomeszsko J, Cnaan A, Stallings V. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis. J Pediatr. 1996;129:119-129.
38. Konstan M, Butler S, Johnson C, Wagener J, Lai H, Morgan W. The relationship between nutritional status in early life and pulmonary function in cystic fibrosis. Breckenridge, Colo, 2000.
39. Schidlow DV. Cystic Fibrosis: From theory to practice, management, assessment and new directions. Philadelphia, Pa: MCP Hahneman University School of Medicine, 2000.
40. Kleinman RE, ed. Pediatric Nutrition Handbook, Assessment of Nutritional Status. Fourth ed. Elk Grove Village, III: American Academy of Pediatrics, 1998.
41. Beker LT, Fink RJ. Cysitc Fibrosis Center Quality Assurance Report on Nutrition Assessment. Washington, DC, 1998.
42. Erskine JM, Lingard CD, Sontag M, Accurso FJ. Enterai nutrition for patients with cystic fibrosis: Comparison of semi-elemental and nonelemental formula. J Pediatr. 1998;132:265-269.
43. Stark L, Mulvihill M, Powers S, Jelalian E, Keating K, Creveling S, Byrnes-Collins B, Harwood I, Passero M, Light M, DL M, Hovell M. Behavioral intervention to improve calorie intake of children with cystic fibrosis: treatment versus wait list control. J Pediatr Gastroenterol Nutr. 1996;22:240-253.
44. Foster S, Farrell PM. Enhancing nutrition in cystic fibrosis with comprehensive therapies. J Pediatr Gastroenterol Nutr. 1996;22:238-242.
45. Tanner J, Davies P, Phil M. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107:317-329.
46. Lai HC, FitzSimmons SC, Allen DB, Kosorok MR, Rosenstein BJ, Campbell PW, Farrell PM. Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis. N Engl J Med. 2000;342:851-859.